← Back to Clinical Trials
Recruiting NCT06514092

NCT06514092 Study on the Long-Term Risk of Recurrence of Anoperineal Fistula in Crohn's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06514092
Status Recruiting
Phase
Sponsor University Hospital, Toulouse
Condition Crohn Disease
Study Type OBSERVATIONAL
Enrollment 81 participants
Start Date 2024-09-17
Primary Completion 2027-08-01

Trial Parameters

Condition Crohn Disease
Sponsor University Hospital, Toulouse
Study Type OBSERVATIONAL
Phase N/A
Enrollment 81
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-09-17
Completion 2027-08-01
Interventions
anti-TNF therapy and seton drainage

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This research aims to evaluate the long-term recurrence risk of perianal fistulas in Crohn's disease patients who have undergone treatment with anti-TNF therapy and seton drainage.The research seeks to identify factors influencing recurrence and assess the long term effectiveness of these treatments in preventing fistula recurrence. This study will provide insights that could enhance treatment strategies and improve patient outcomes.

Eligibility Criteria

Inclusion Criteria: * Confirmed diagnosis of Crohn's disease * drainage of an anal fistula with seton combined with the initiation of anti-TNF alpha treatment * Patient who was treated in the digestive center of the Toulouse University Hospital for drainage of an anal fistula between January 1, 2000 and December 31, 2010 Exclusion Criteria: Patient followed less than 6 months after seton drainage

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology